Pharmaceutical Executive
In this article, Littler attorneys discuss the potentially far-reaching implications of the U.S. Supreme Court’s pending decision in Christopher v. SmithKline. The article details the debate over whether a class of GlaxoSmithKline pharmaceutical sales representatives qualify for the outside sales exemption under the Fair Labor Standards Act and are therefore not entitled to overtime pay.
